Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Vitamin D Receptor Gene Polymorphisms Are Not Related To Bone Turnover, Rate Of Bone Loss, And Bone Mass In Postmenopausal Women: The OFELY Study

P. Garnero, O. Borel, E. Sornay-Rendu, M. Arlot, P. Delmas
Published 1996 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Vitamin D receptor (VDR) gene polymorphisms have been reported to account for most of the well established genetic influence on bone mineral density (BMD). However, discordant studies have been published and it is still not clear whether VDR genotypes influence bone mass accretion and/or postmenopausal bone loss. In this study, we analyzed VDR gene polymorphisms, i.e., that of BsmI, ApaI, and TaqI restriction enzymes in 268 untreated postmenopausal women 1–26 years postmenopausal. There were 37 BBAA homozygote (absence of BsmI and ApaI restriction sites on both alleles), 55 bbaa homozygote (presence of restriction sites on both alleles), and 176 heterozygotes. At baseline, women between the three genotypes did not differ significantly in age, years since menopause, body mass index (BMI), nor dietary calcium intake. We found no relationship between VDR genotypes and bone turnover assessed by three serum markers of bone formation and three urinary bone resorption markers, nor with BMD measured at the spine, hip, forearm, and whole body by dual‐energy X‐ray absorptiometry (DXA). Rates of bone loss assessed by repeated DXA measurements over 2 years were highly significant (p = 0.02–0.0001) at all skeletal sites except for the lumbar spine but did not differ between genotypes at any sites either before or after adjustment for potential confounding factors such as years since menopause, BMI, calcium intake, serum 25 hydroxyvitamin D levels, and baseline BMD. When we restricted the analysis to early postmenopausal women, within 10 years of menopause (n = 128), lumbar spine bone loss became significant, but no significant difference between VDR genotypes in the rate of bone loss measured at any site was found. We conclude that VDR genotypes are not predictive of bone turnover, rate of postmenopausal bone loss, and bone mass in either early or late postmenopausal women. In a subgroup of women with a low calcium intake (below 600 mg/day), we also found no significant differences between genotypes in BMD and the rate of bone loss measured at any site, although the sample size (n = 64) may be too small to detect small differences. In conclusion, these data, along with the absence of relationships between VDR gene polymorphisms and peak bone mass that we recently reported, suggest that the determination of VDR genotypes is probably not a useful clinical test for the risk assessment of osteoporosis.
This paper references
Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates
C. Slemenda (1991)
Lack of a high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women.
J. E. Looney (1995)
Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
D. Uebelhart (1991)
The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women
J. Fleet (1995)
Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain
T. Spector (1995)
Genetic determinants of bone mineral content at the spine and radius: a twin study.
J. Dequeker (1987)
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density
S. Ferrari (1995)
Genetic determinants of bone mass in adults. A twin study.
N. Pocock (1987)
Vitamin-D-receptor-gene polymorphism and bone loss
R. Keen (1995)
Genetic influence on bone turnover in postmenopausal twins.
P. Garnero (1996)
Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
P. Garnero (1994)
Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype.
B. Dawson-Hughes (1995)
Prediction of bone density from vitamin D receptor alleles
N. Morrison (1994)
A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
B. Dawson-Hughes (1990)
The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women
Lawrence B. Riggs (1995)
Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women
J. Johansen (1988)
Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
P. Garnero (1994)
Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
P. Garnero (1993)
Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.
F. G. Hustmyer (1994)
Direct, enzyme‐linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption
S. Robins (1994)
Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake
E. Krall (1995)
Vitamin D receptor genotypes in osteoporosis
H. Melhus (1994)
Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women
P. Garnero (1995)
A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine
D. A. Hanson (1992)
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.
N. Morrison (1992)

This paper is referenced by
Association between Vitamin D receptor polymorphisms and the rate of bone loss in elderly women—importance of adjusting for dietary and lifestyle factors
P. Rapuri (2004)
Association of a Polymorphism of the Transforming Growth Factor‐β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women
Y. Yamada (1998)
A method for meta-analysis of molecular association studies.
A. Thakkinstian (2005)
2 The Genetics of Osteoporosis Progress in Mice, not Man
E. Seeman (2002)
Vitamin D Receptor Alleles and Bone's Response to Physical Activity
T. Järvinen (1998)
Commentary: vitamin D receptor polymorphism and bone mineral density: effect size in Caucasians means detection is uncertain in small studies.
N. Morrison (2004)
4 – Diet and control of osteoporosis
K. Cashman (2004)
Chapter 69 – Osteoporosis
Roland D. Chapurlat (2016)
Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study.
R. W. Bentley (2012)
Critical periods in human growth and their relationship to diseases of aging.
N. Cameron (2002)
How About Vitamin D Receptor Polymorphisms?
H. Pols (1998)
Lack of relationship between vitamin D receptor genotype and forearm bone gain in healthy children, adolescents, and young adults.
M. Gunnes (1997)
Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis
A. Parés (2005)
Genetics, calcium intake and osteoporosis.
J. Eisman (1998)
Estrogen receptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women.
H. Lau (2002)
Prediction of changes in bone mineral in early postmenopausal women
P. Vestergaard (2000)
Vitamin D receptor gene haplotype is associated with body height and bone size.
Y. Fang (2007)
A familial risk profile for osteoporosis
L. Henderson (2000)
Functional foods and bone health
K. Cashman (2005)
Fatores envolvidos no pico de massa óssea
C. A. Brandão (1999)
Quadriceps and Grip Strength Are Related to Vitamin D Receptor Genotype in Elderly Nonobese Women
P. Geusens (1997)
Papel de la tipificación genética múltiple (receptores de vitamina D y estrógenos) en la determinación del riesgo de fractura
M. T. Zarrabeitia (2000)
Vitamin D Receptor Fok1 Polymorphisms Affect Calcium Absorption, Kinetics, and Bone Mineralization Rates During Puberty
S. Abrams (2005)
CHAPTER 9 – Peak Bone Mass and Its Regulation
J. Bonjour (2003)
Vitamin D receptor and estrogen receptor gene polymorphisms in postmenopausal Danish women: no relation to bone markers or serum lipoproteins
Y. Bagger (2000)
Genes influencing variation in serum osteocalcin concentrations are linked to markers on chromosomes 16q and 20q.
B. Mitchell (2000)
The genetics of osteoporosis: vitamin D receptor polymorphisms.
R. Wood (1998)
Polimorfismo del gen del receptor de la vitamina D, masa ósea y recambio óseo en mujeres con osteoporosis postmenopáusica
R. Garrofé (2000)
Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis
L. Lakatos (2002)
Are vitamin D receptor polymorphisms associated with bone mineral density? A meta‐analysis
G. Cooper (1996)
Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis
A. Vogel (2002)
Bone mass pharmacogenetics and ethnic health implications Mini-review
Francesco Massarta (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar